Authors
Shevchenko Yu.L., Matveev S.A., Gudymovich V.G.
St. George thoracic and cardiovascular surgery clinic Pirogov National Medical and Surgical Center, Moscow
Abstract
In this article, we describe our pioneering experience of implantation of human embryonic cardiomyocytes to a patient with severe ischemic heart lesions. In 1998, we injected suspension of human embryonic cardiomyocytes into the myocardium of a 58-year-old male patient during coronary artery bypass surgery. Long follow-up (23 years) shows that the patient, who is currently 81 years old, feels good and has a good quality of life. He has no signs of circulatory insufficiency. No complications associated with cell implantation have ever been reported during this period.
Keywords: ischemic heart disease, cell replacement therapy, implantation of embryonic cardiomyocytes.
References
1. SHevchenko YUL, Matveev SA, Pinaev GP, et al. Pervyj opyt implantacii embrional’nyh kardiomiocitov (EK) cheloveka v kompleksnom lechenii bol’nyh s ishemicheskoj bolezn’yu serdca. IV Vserossijskij s”ezd SSKH. M.,1998. P.85.
2. SHevchenko YUL, Matveev SA. Kletochnye tekhnologii v serdechno-sosudistoj hirurgii. M.: Medicina, 2005. 160 р.
3. Jackman CP, Shadrin IY, Carlson AL, Bursac N. Human Cardiac Tissue Engineering: From Pluripotent Stem Cells to Heart Repair. Curr Opin Chem Eng. 2015 Feb; 7: 57-64. doi: 10.1016/j.coche.2014.11.004.
4. Lee CA, Sinha S, Fitzpatrick E, Dhawan A. Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine. J Mol Med (Berl). 2018; 96(6): 469-481. doi: 10.1007/s00109-018-1638-5.
5. Pepper AR, Pawlick R, Brun A, et al. Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site. Stem Cell Reports. 2017; 8(6): 1689-1700. doi: 10.1016/j.stemcr.2017.05.004.
6. Shevchenko YuL. Experimental Validation of Embryonic Cardiomyocyte Implantation in Complex Therapy of Myocardial Failure. Progress in Biomedical Research. 1999; 4(5): 468-474.
